Organisation: Allianz

CMA rebuffs “ambiguous” documents claim in Prochlorperazine appeal

Advanz’s argument that unclear communications should tip in favour of the appellants challenging the UK enforcer’s Prochlorperazine cartel decision incorrectly interprets past case law on ambiguous documents, the country’s specialist competition tribunal has heard.

01 August 2023

CMA discarded oral testimonies to reach Prochlorperazine decision, Advanz says

The UK’s antitrust watchdog has wrongly relied on its own interpretation of emails exchanged among members of the alleged Prochlorperazine cartel, rather than actual oral testimonies, Advanz’s counsel has told the specialist competition tribunal.

31 July 2023

Unlock unlimited access to all Global Competition Review content